Samsung Biologics Co.,Ltd.
207940
Rang în acțiuni
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Preț acțiune
$1,028.49
Capitalizare de piață
$47.88B
Schimbare (1 zi)
-3.67%
Schimbare (1 an)
-18.37%
Țară
KR
Tranzacționează Samsung Biologics Co.,Ltd. (207940)
Categorie
Healthcare
Istoricul spliturilor pentru Samsung Biologics Co.,Ltd. (207940)
Acțiunea Samsung Biologics Co.,Ltd. (simbol: 207940) a trecut printr-un total de 1 splituri.
Cel mai recent split a avut loc pe Oct 30, 2025.
O acțiune 207940 cumpărată înainte de Oct 30, 2025 este echivalentă astăzi cu 0.650391 acțiuni 207940.
Cel mai recent split a avut loc pe Oct 30, 2025.
O acțiune 207940 cumpărată înainte de Oct 30, 2025 este echivalentă astăzi cu 0.650391 acțiuni 207940.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| 2025-10-30 | 650391:1000000 | x0.650391 | x0.650391 |
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
